How to meet physicians needs for drug and treatment information?
IQVIA ChannelDynamics® Preference and Perception 2020 Surveys
The ChannelDynamics Preference and Perception Surveys are an annual opportunity to gauge marketing preferences and perception of information provided by drug companies to Health Care Practitioners (HCPs).
Is remote engagement sufficient to meet HCPs needs for drug and treatment information?
Which remote channels should life science companies focus on to improve engagement?
To better understand HCPs opinion, the global IQVIA ChannelDynamics “online daily diary” panel of ~30,000 HCPs across 35 countries was surveyed in 2020, to assess five key questions:
- What are HCPs most preferred sources of information?
- In a post-Covid-19 context, will remote interactions with reps be sufficient?
- Is information provided by pharma companies up-to-date and relevant?
- And is this information convenient to access and coherently presented?
- In the context of Covid-19, which remote channels are the highest priority for improving communication?